Runfeng Jing

450 total citations
9 papers, 348 citations indexed

About

Runfeng Jing is a scholar working on Cell Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Runfeng Jing has authored 9 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cell Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Runfeng Jing's work include Skin and Cellular Biology Research (4 papers), Nail Diseases and Treatments (3 papers) and Cancer-related cognitive impairment studies (3 papers). Runfeng Jing is often cited by papers focused on Skin and Cellular Biology Research (4 papers), Nail Diseases and Treatments (3 papers) and Cancer-related cognitive impairment studies (3 papers). Runfeng Jing collaborates with scholars based in United States, Switzerland and Sweden. Runfeng Jing's co-authors include Omar Skalli, Yihang Pan, Loren E. Wold, Peter J. Reiser, Donna O. McCarthy, Sabahattin Bicer, Diana M. Norden, Jonathan P. Godbout, Ulrika Wilhelmsson and Milos Pekny and has published in prestigious journals such as The FASEB Journal, Journal of Cell Science and Brain Behavior and Immunity.

In The Last Decade

Runfeng Jing

9 papers receiving 345 citations

Peers

Runfeng Jing
Shih‐Hsiu J. Wang United States
Myrthe Mampay United Kingdom
Samantha Zunich United States
Chelsey B. Reed United States
Sheena Chew United States
Nathan Tu United States
Carolyn Sloan United Kingdom
Runfeng Jing
Citations per year, relative to Runfeng Jing Runfeng Jing (= 1×) peers Lisa Greve Routhe

Countries citing papers authored by Runfeng Jing

Since Specialization
Citations

This map shows the geographic impact of Runfeng Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runfeng Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runfeng Jing more than expected).

Fields of papers citing papers by Runfeng Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runfeng Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runfeng Jing. The network helps show where Runfeng Jing may publish in the future.

Co-authorship network of co-authors of Runfeng Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Runfeng Jing. A scholar is included among the top collaborators of Runfeng Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runfeng Jing. Runfeng Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Stevens, Sarah, Markus Velten, Dane J. Youtz, et al.. (2015). Losartan treatment attenuates tumor-induced myocardial dysfunction. Journal of Molecular and Cellular Cardiology. 85. 37–47. 24 indexed citations
2.
Norden, Diana M., Sabahattin Bicer, Runfeng Jing, et al.. (2014). Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue. Physiology & Behavior. 140. 230–235. 33 indexed citations
3.
Norden, Diana M., Runfeng Jing, Christopher J. Henry, et al.. (2014). 24. Tumor progression increases neuroinflammation, fatigue and depressive-like behavior without altering muscle function. Brain Behavior and Immunity. 40. e7–e8. 6 indexed citations
4.
Norden, Diana M., Sabahattin Bicer, Runfeng Jing, et al.. (2014). Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function. Brain Behavior and Immunity. 43. 76–85. 88 indexed citations
5.
Pan, Yihang, Runfeng Jing, Aaron Pitre, Briana J. Williams, & Omar Skalli. (2008). Intermediate filament protein synemin contributes to the migratory properties of astrocytoma cells by influencing the dynamics of the actin cytoskeleton. The FASEB Journal. 22(9). 3196–3206. 37 indexed citations
6.
Jing, Runfeng, Ulrika Wilhelmsson, Li-Zhen Li, et al.. (2007). Synemin is expressed in reactive astrocytes in neurotrauma and interacts differentially with vimentin and GFAP intermediate filament networks. Journal of Cell Science. 120(7). 1267–1277. 81 indexed citations
7.
Schmitt‐Graeff, Annette, Runfeng Jing, Roland Nitschke, Alexis Desmoulière, & Omar Skalli. (2006). Synemin expression is widespread in liver fibrosis and is induced in proliferating and malignant biliary epithelial cells. Human Pathology. 37(9). 1200–1210. 25 indexed citations
8.
Jing, Runfeng, Gianpaolo Pizzolato, Richard M. Robson, Giulio Gabbiani, & Omar Skalli. (2005). Intermediate filament protein synemin is present in human reactive and malignant astrocytes and associates with ruffled membranes in astrocytoma cells. Glia. 50(2). 107–120. 41 indexed citations
9.
Lü, Ying, Runfeng Jing, David C. Yeomans, & George D. Pappas. (2004). Porcine chromaffin cells, culture, and transplant for antinociceptive effects in rodents and primates. Neurological Research. 26(7). 707–712. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026